William Varnado is an Oncology physician. OpenAlex indexes 9 publications with 705 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5131 Odonovan Dr
Baton Rouge, LA 708084791
Telephone
225-767-1311Provider last certified this registry record 18 May 2021.
Industry payments
50 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year202512 payments
- Merck Sharp & Dohme LLCProgram year20256 payments
- Celgene CorporationProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
49.6%Other antiemetics42.6%Fosaprepitant100%Part B, office-administered≥19 patientsSerotonin-3 Receptor Antagonist6.3%Palonosetron hcl50%Ondansetron hydrochloride48%Ondansetron Odt2%Part D + Part B≥30 patients+ 3 more classes in this area
Cancer & immunology
37.9%PD-1 inhibitor34%Pembrolizumab100%Part B, office-administered≥14 patientsAromatase Inhibitor2.5%Anastrozole67%Letrozole27%Exemestane6%Part D≥107 patients+ 7 more classes in this area
Sensory organs
9.6%Corticosteroid9.6%Dexamethasone sodium phosphate100%Part B, office-administered≥43 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Use of 18F-FDG PET/CT as an Initial Staging Procedure for Stage II–III Breast Cancer: A Multicenter Value Analysis
Journal of the National Comprehensive Cancer Network
2020 - Real world vs. clinical trial outcomes of triple class refractory penta-exposed multiple myeloma (MM)
Clinical Lymphoma Myeloma & Leukemia
2019 - Financial distress amongst older adults with gastrointestinal (GI) malignancies.
Journal of Clinical Oncology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”